One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Patient-Reported Outcome Information Collected from Lupus Patients Using a Mobile Application: Compliance and Validation
Kristy Bell,Claire Dykas,Bridget Muckian,Brooke Williams,Hope Rainey,Maggy Comberg,Mary Mora,Katherine A. Owen,Peter E. Lipsky
doi : 10.1002/acr2.11370
Volume 4, Issue 2 p. 99-109
Patient-reported outcomes (PROs) can provide critical information concerning the impact of a disease on an individual. Mobile technology to collect PRO data in an electronic format (ePRO) allows for frequent assessment in the person's regular environment. The goal of this study was to assess the compliance with a phone application (app) and validate ePRO information in individuals with systemic lupus erythematosus (SLE).
Clinical Image: Calcinosis cutis universalis in a patient with polymyositis/scleroderma overlap syndrome
Katie Carbonell,Nicole Droz
doi : 10.1002/acr2.11371
Volume 4, Issue 2 p. 110-110
Identification and Prediction of Fatigue Trajectories in People With Rheumatoid Arthritis
Susanne Pettersson,Ingrid Demmelmaier,Birgitta Nordgren,Alyssa B. Dufour,Christina H. Opava
doi : 10.1002/acr2.11374
Volume 4, Issue 2 p. 111-118
We aimed to identify groups demonstrating different long-term trajectories of fatigue among people with rheumatoid arthritis and determine baseline predictors for these trajectories.
Journal Club: Efficacy of Tocilizumab in Early Systemic Sclerosis–Related Interstitial Lung Disease
Vivekanand Tiwari,William F.C. Rigby
doi : 10.1002/acr2.11358
Volume 4, Issue 2 p. 119-122
Reexamining Remission Definitions in Rheumatoid Arthritis: Considering Disease Activity Score in 28 Joints, C-Reactive Protein, and Patient Global Assessment
David T. Felson MD, MPH,Diane Lacaille MD, MHSc,Michael P. LaValley PhD,Daniel Aletaha MD, MS, MBA
doi : 10.1002/acr2.11345
Volume 4, Issue 2 p. 123-127
Rapid Adoption of Telemedicine in Rheumatology Care During the COVID-19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees
Su-Ann Yeoh,Kristen Young,Michael Putman,Sebastian Sattui,Richard Conway,Elizabeth Graef,Adam Kilian,Maximilian Konig,Jeffrey Sparks,Manuel Ugarte-Gil,Laura Upton,Francis Berenbaum,Suleman Bhana,Wendy Costello,Jonathan Hausmann,Pedro Machado,Philip Robinson,Emily Sirotich,Paul Sufka,Jinoos Yazdany,Jean Liew,Rebecca Grainger,Zachary Wallace,Arundathi Jayatilleke, on behalf of The Global Rheumatology Alliance
doi : 10.1002/acr2.11355
Volume 4, Issue 2 p. 128-133
To evaluate the impact of telemedicine use during the coronavirus disease 2019 (COVID-19) pandemic on rheumatology trainees.
Clinical Images: Cardiovascular magnetic resonance to detect and monitor inflammatory myocarditis in systemic lupus erythematosus
Omer N. Pamuk,W. Patricia Bandettini,Jalal Vargha,Sujata M. Shanbhag,Sarfaraz Hasni
doi : 10.1002/acr2.11364
Volume 4, Issue 2 p. 134-135
Telemedicine Visits During COVID-19 Improved Clinic Show Rates
Reem Alkilany,Yasir Tarabichi,Raymond Hong
doi : 10.1002/acr2.11372
Volume 4, Issue 2 p. 136-141
We aimed to explore the impact of telehealth in the setting of COVID-19 on patient access to ambulatory rheumatologic care at our academic public health system and to determine whether telemedicine visits had a beneficial impact on access to our rheumatology ambulatory clinics.
Acceptability of an Adolescent Self-Management Program for Juvenile Idiopathic Arthritis
Kelsey Chomistek,Cheryl Barnabe,Syeda Farwa Naqvi,Kathryn A. Birnie,Nicole Johnson,Nadia Luca,Paivi Miettunen,Maria J. Santana,Jennifer Stinson,Heinrike Schmeling
doi : 10.1002/acr2.11373
Volume 4, Issue 2 p. 142-151
The study objective was to test the acceptability of a self-management program (SMP) for adolescents with juvenile idiopathic arthritis (JIA) focused on disease information, self-management, and social support needs.
Optimization of Human Mesenchymal Stem Cells for Rheumatoid Arthritis: Implications for Improved Therapeutic Outcomes
Maya Breitman,Tracey L. Bonfield,Arnold I. Caplan,Hillard M. Lazarus,Maricela Haghiac,Susan LaSalvia,Jane Reese-Koc,Nora G. Singer
doi : 10.1002/acr2.11356
Volume 4, Issue 2 p. 152-160
Seropositive rheumatoid arthritis (RA) is a chronic autoimmune disease that is rarely “cured.” Human mesenchymal stem cells (hMSCs) are known to reduce inflammation and restore immune homeostasis. However, methods for predicting therapeutic hMSC potency have not been established. The goal of these studies was to use and refine an ex vivo functional assay that determines potency of hMSCs and can then be validated in clinical trials as a potency measure of hMSCs used therapeutically to treat RA.
Relation of MRI-Detected Features of Patellofemoral Osteoarthritis to Pain, Performance-Based Function, and Daily Walking: The Multicenter Osteoarthritis Study
J. L. Maxwell,T. Neogi,Kay M. Crossley,Erin M. Macri,Dan White,A. Guermazi,F. W. Roemer,M. C. Nevitt,C. E. Lewis,J. C. Torner,J. J. Stefanik
doi : 10.1002/acr2.11361
Volume 4, Issue 2 p. 161-167
The study objective was to determine the relationship of magnetic resonance imaging (MRI)-detected features of patellofemoral joint osteoarthritis to pain and functional outcomes.
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated Vasculitis
Paul A. Monach,Roscoe L. Warner,Robert Lew,Gunnar Tómasson,Ulrich Specks,John H. Stone,Fernando C. Fervenza,Gary S. Hoffman,Cees G. M. Kallenberg,Carol A. Langford,Philip Seo,E. William St. Clair,Robert Spiera,Kent J. Johnson,Peter A. Merkel
doi : 10.1002/acr2.11366
Volume 4, Issue 2 p. 168-176
Improved biomarkers of current disease activity and prediction of relapse are needed in antineutrophil cytoplasmic antibody–associated vasculitis (AAV). For clinical relevance, biomarkers must perform well longitudinally in patients on treatment and in patients with nonsevere flares.
Analysis of the Immunogenicity from Abatacept-Treated Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Findings From Two Phase III Clinical Trials
Johanna R. Mora,Robert Wong,Mehmooda Shaikh,Margarita Askelson
doi : 10.1002/acr2.11375
Volume 4, Issue 2 p. 177-186
The goal of this article is to present the analysis of anti-abatacept antibody data from children with polyarticular-course juvenile idiopathic arthritis (pJIA), treated with abatacept. The data are from 395 participants with pJIA from two abatacept registrational trials.
Outpatient Use of Antimicrobials in Patients With Rheumatoid Arthritis Before and After Treatment With Tumor Necrosis Factor Inhibitors: A Nationwide Retrospective Cohort Study
Aron H. Bjornsson,Olafur Palsson,Mar Kristjansson,Petur S. Gunnarsson,Gerdur Grondal,Bjorn Gudbjornsson,Thorvardur J. Love,on behalf of ICEBIO
doi : 10.1002/acr2.11382
Volume 4, Issue 2 p. 187-194
The objective of this study was to investigate the effect of tumor necrosis factor ? inhibitor (TNFi) initiation on the use of antimicrobials among biologic-naïve patients with rheumatoid arthritis (RA).
